{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:27:12Z","timestamp":1785338832376,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["BC-RG-16 - 2016"],"award-info":[{"award-number":["BC-RG-16 - 2016"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["319330"],"award-info":[{"award-number":["319330"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jbo.2022.100432","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T12:11:21Z","timestamp":1652443881000},"page":"100432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix"],"prefix":"10.1016","volume":"34","author":[{"given":"Scott A.","family":"Gunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4892-9666","authenticated-orcid":false,"given":"Lauren M.","family":"Kreps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Landon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-6184","authenticated-orcid":false,"given":"Jacob S.","family":"Ilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-475X","authenticated-orcid":false,"given":"Christina L.","family":"Addison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jbo.2022.100432_b0005","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J. Clin."},{"issue":"8 Suppl","key":"10.1016\/j.jbo.2022.100432_b0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis","volume":"80","author":"Mundy","year":"1997","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2022.100432_b0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2009.07.005","article-title":"Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis","volume":"289","author":"Luo","year":"2010","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.jbo.2022.100432_b0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/cam.3.4.9458","article-title":"The role of focal adhesion kinase in tumor initiation and progression","volume":"3","author":"Provenzano","year":"2009","journal-title":"Cell Adhes. Migr."},{"issue":"51","key":"10.1016\/j.jbo.2022.100432_b0025","doi-asserted-by":"crossref","first-page":"20302","DOI":"10.1073\/pnas.0710091104","article-title":"Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression","volume":"104","author":"Lahlou","year":"2007","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/labinvest.3780211","article-title":"Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression","volume":"81","author":"Stanzione","year":"2001","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.trsl.2010.05.001","article-title":"Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival","volume":"156","author":"Ding","year":"2010","journal-title":"Transl. Res."},{"issue":"12","key":"10.1016\/j.jbo.2022.100432_b0040","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2010.06.004","article-title":"Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer","volume":"41","author":"Park","year":"2010","journal-title":"Hum. Pathol."},{"issue":"6","key":"10.1016\/j.jbo.2022.100432_b0045","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hed.23038","article-title":"Focal adhesion kinase overexpression: correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma","volume":"35","author":"de Vicente","year":"2013","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.jbo.2022.100432_b0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00432-012-1342-8","article-title":"Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer","volume":"139","author":"Ji","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"46","key":"10.1016\/j.jbo.2022.100432_b0055","doi-asserted-by":"crossref","first-page":"45368","DOI":"10.1074\/jbc.M308786200","article-title":"Beta1 integrin\/focal adhesion kinase-mediated signaling induces intercellular adhesion molecule 1 and receptor activator of nuclear factor kappaB ligand on osteoblasts and osteoclast maturation","volume":"278","author":"Nakayamada","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.jbo.2022.100432_b0060","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.4049\/jimmunol.168.11.5824","article-title":"Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints","volume":"168","author":"Matsumoto","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbo.2022.100432_b0065","doi-asserted-by":"crossref","first-page":"d1219","DOI":"10.2741\/1117","article-title":"PYK2 and FAK in osteoclasts","volume":"8","author":"Xiong","year":"2003","journal-title":"Front Biosci"},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bone.2007.01.024","article-title":"Reconciling the roles of FAK in osteoblast differentiation, osteoclast remodeling, and bone regeneration","volume":"41","author":"Kim","year":"2007","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.jbo.2022.100432_b0075","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.biochi.2010.07.005","article-title":"Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways","volume":"92","author":"Sen","year":"2010","journal-title":"Biochimie"},{"issue":"1-2","key":"10.1016\/j.jbo.2022.100432_b0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-009-0256-5","article-title":"Fibronectin\u2013integrin mediated signaling in human cervical cancer cells (SiHa)","volume":"336","author":"Maity","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.jbo.2022.100432_b0085","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-07-5155","article-title":"Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271","volume":"68","author":"Roberts","year":"2008","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.jbo.2022.100432_b0090","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1021\/jm800483v","article-title":"A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth","volume":"51","author":"Golubovskaya","year":"2008","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.jbo.2022.100432_b0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/cancers10090278","article-title":"Targeting focal adhesion kinase using inhibitors of protein-protein interactions","volume":"10","author":"Mousson","year":"2018","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jbo.2022.100432_b0100","doi-asserted-by":"crossref","first-page":"C657","DOI":"10.1152\/ajpcell.00377.2010","article-title":"Akt directly regulates focal adhesion kinase through association and serine phosphorylation: implication for pressure-induced colon cancer metastasis","volume":"300","author":"Wang","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.jbo.2022.100432_b0105","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1074\/jbc.M112.420497","article-title":"Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo","volume":"288","author":"Fan","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.jbo.2022.100432_b0110","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/cas.13256","article-title":"Antitumor effect of focal adhesion kinase inhibitor PF562271 against human osteosarcoma in vitro and in vivo","volume":"108","author":"Hu","year":"2017","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.jbo.2022.100432_b0115","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.yexcr.2011.02.008","article-title":"Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo","volume":"317","author":"Kurio","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.jbo.2022.100432_b0120","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/cncr.23429","article-title":"Dual focal adhesion kinase\/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases","volume":"112","author":"Bagi","year":"2008","journal-title":"Cancer"},{"issue":"46","key":"10.1016\/j.jbo.2022.100432_b0125","doi-asserted-by":"crossref","first-page":"29309","DOI":"10.1074\/jbc.272.46.29309","article-title":"Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells","volume":"272","author":"Takeuchi","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.jbo.2022.100432_b0130","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1359\/jbmr.2001.16.10.1772","article-title":"Focal adhesion kinase activity is required for bone morphogenetic protein\u2013Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells","volume":"16","author":"Tamura","year":"2001","journal-title":"J. Bone Mineral Res."},{"issue":"12","key":"10.1016\/j.jbo.2022.100432_b0135","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/nprot.2009.191","article-title":"Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo","volume":"4","author":"Debacq-Chainiaux","year":"2009","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.jbo.2022.100432_b0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molonc.2011.10.004","article-title":"Focal adhesion kinase inhibitors are potent anti-angiogenic agents","volume":"5","author":"Cabrita","year":"2011","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.jbo.2022.100432_b0145","doi-asserted-by":"crossref","first-page":"e0150567","DOI":"10.1371\/journal.pone.0150567","article-title":"Focal adhesion kinase inhibitors in combination with erlotinib demonstrate enhanced anti-tumor activity in non-small cell lung cancer","volume":"11","author":"Howe","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jbo.2022.100432_b0150","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jcb.25430","article-title":"Pyk2 and megakaryocytes regulate osteoblast differentiation and migration via distinct and overlapping mechanisms","volume":"117","author":"Eleniste","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"25","key":"10.1016\/j.jbo.2022.100432_b0155","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.0701421104","article-title":"Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis","volume":"104","author":"Buckbinder","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.jbo.2022.100432_b0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-6-71","article-title":"Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF","volume":"6","author":"Fujita","year":"2007","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.jbo.2022.100432_b0165","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1083\/jcb.200508130","article-title":"Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling","volume":"172","author":"Lengner","year":"2006","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2007.11.031","article-title":"Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation","volume":"29","author":"Lim","year":"2008","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.jbo.2022.100432_b0175","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.2003.18.10.1842","article-title":"BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop","volume":"18","author":"Rawadi","year":"2003","journal-title":"J. Bone Mineral Res."},{"issue":"4","key":"10.1016\/j.jbo.2022.100432_b0180","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00223-017-0259-2","article-title":"Bone alkaline phosphatase and tartrate-resistant acid phosphatase: potential co-regulators of bone mineralization","volume":"101","author":"Halling Linder","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0169-6009(91)90100-E","article-title":"Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate","volume":"14","author":"Bellows","year":"1991","journal-title":"Bone Mineral"},{"issue":"5","key":"10.1016\/j.jbo.2022.100432_b0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S8756-3282(01)00415-X","article-title":"Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells","volume":"28","author":"Gallea","year":"2001","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jbo.2022.100432_b0200","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jbmr.561","article-title":"Interactions between extracellular signal-regulated kinase 1\/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity","volume":"27","author":"Ge","year":"2012","journal-title":"J. Bone Mineral Res."},{"issue":"9","key":"10.1016\/j.jbo.2022.100432_b0205","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1371\/journal.pone.0000837","article-title":"GSK-3beta controls osteogenesis through regulating Runx2 activity","volume":"2","author":"Kugimiya","year":"2007","journal-title":"PLoS ONE"},{"issue":"Pt 1","key":"10.1016\/j.jbo.2022.100432_b0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj2960015","article-title":"Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling","volume":"296","author":"Sutherland","year":"1993","journal-title":"Biochem. J."},{"issue":"6559","key":"10.1016\/j.jbo.2022.100432_b0215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jbo.2022.100432_b0220","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2011.07.009","article-title":"Akt phosphorylates and regulates the osteogenic activity of Osterix","volume":"411","author":"Choi","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0225","doi-asserted-by":"crossref","first-page":"13551","DOI":"10.1038\/s41598-018-31853-0","article-title":"Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3","volume":"8","author":"Kawane","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jbo.2022.100432_b0230","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1002\/jcp.29374","article-title":"Focal adhesion kinase promotes BMP2-induced osteogenic differentiation of human urinary stem cells via AMPK and Wnt signaling pathways","volume":"235","author":"Sun","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.jbo.2022.100432_b0235","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1210\/endo.140.5.6704","article-title":"Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro","volume":"140","author":"Suzawa","year":"1999","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.jbo.2022.100432_b0240","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1083\/jcb.201109067","article-title":"Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression","volume":"197","author":"Lim","year":"2012","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.jbo.2022.100432_b0245","doi-asserted-by":"crossref","first-page":"e3707","DOI":"10.1371\/journal.pone.0003707","article-title":"p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner","volume":"3","author":"Molchadsky","year":"2008","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0250","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yexcr.2006.09.013","article-title":"Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells","volume":"313","author":"Salasznyk","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jbo.2022.100432_b0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.etap.2016.07.013","article-title":"Tideglusib induces apoptosis in human neuroblastoma IMR32 cells, provoking sub-G0\/G1 accumulation and ROS generation","volume":"46","author":"Mathuram","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.jbo.2022.100432_b0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/bjc.2016.190","article-title":"Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways","volume":"115","author":"Zhang","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"18","key":"10.1016\/j.jbo.2022.100432_b0265","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1002\/cam4.2647","article-title":"TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma","volume":"8","author":"Moritake","year":"2019","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.jbo.2022.100432_b0270","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/0008-5472.CAN-12-1944","article-title":"High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma","volume":"73","author":"Crompton","year":"2013","journal-title":"Cancer Res."},{"issue":"31","key":"10.1016\/j.jbo.2022.100432_b0275","doi-asserted-by":"crossref","first-page":"33024","DOI":"10.1074\/jbc.M313265200","article-title":"Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase\/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway","volume":"279","author":"Xia","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jbo.2022.100432_b0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijc.25025","article-title":"The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt\/NF-kappaB signaling pathway in colorectal carcinomas, International journal of cancer","volume":"127","author":"Chen","year":"2010","journal-title":"J. Internat. du Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2022.100432_b0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1083\/jcb.139.2.529","article-title":"Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase","volume":"139","author":"Xiong","year":"1997","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.jbo.2022.100432_b0290","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/emmm.201000106","article-title":"Endothelial FAK is required for tumour angiogenesis","volume":"2","author":"Tavora","year":"2010","journal-title":"EMBO Mol. Med."},{"issue":"Pt 5","key":"10.1016\/j.jbo.2022.100432_b0295","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1242\/jcs.042770","article-title":"Akt promotes BMP2-mediated osteoblast differentiation and bone development","volume":"122","author":"Mukherjee","year":"2009","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.jbo.2022.100432_b0300","doi-asserted-by":"crossref","first-page":"e112566","DOI":"10.1371\/journal.pone.0112566","article-title":"Akt activation is required for TGF-beta1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts","volume":"9","author":"Suzuki","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137422000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137422000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:31:01Z","timestamp":1778848261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137422000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"alternative-id":["S2212137422000227"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2022.100432","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2022.100432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100432"}}